booster doses are expected to be offered quickly to the 15 million Americans who received a J&J shot as their primary, and the 69 million inoculated with the Moderna jab. The CDC’s decision ...

At the moment only Pfizer/BioNTech's Comirnaty vaccine has been approved by the FDA for booster use, but a decision by the agency is expected in the coming days for the Moderna and J&J jabs.

The U.S. government is going to pay a lot more for Covid-19 booster shots than it used to, and one Senator from Vermont is not happy about it. The read more, check out the full story at STAT ...

Boosters aren’t currently recommended for ... Just like any vaccine authorized in the U.S., the Pfizer-BioNTech, Moderna and J&J COVID-19 shots have gone through a rigorous review process ...

It looked at differences between patients given a Moderna booster after having had two jabs of the Pfizer vaccine and those who received the Pfizer vaccine three times. While about 70 percent of ...

The updated Moderna and Pfizer shots target the KP.2 variant, known as one of the FLiRT subtypes of omicron. The Novavax booster targets the JN.1 strain. Both of those strains were dominant ...

The U.S. Centers for Disease Control and Prevention’s outside panel of vaccine experts on Tuesday discussed narrowing ...